Tag: AnQlar
Virpax Pharmaceuticals extends its development and commercialization rights for AnQlar™ through a worldwide licensing agreement
– AnQlar™ has already demonstrated antiviral activity against influenza and SARS-CoV-2 in three preclinical studies – — The FDA has notified Virpax that the company is authorized to file an…